Delivery Order SPE2DB20D3101-SPE2DB25FRWU5
Award Date 9/26/25
Potential Completion Date 9/29/25
Potential Value $2.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $4,059.35 to AmerisourceBergen Drug Corp for Hemabate 250 MCG/ML ampules, with an ultimate completion date of August 20, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and represents a small-value pharmaceutical supply transaction. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters and primary...
- The Defense Logistics Agency awarded a $1,271.85 firm fixed price delivery order to AmerisourceBergen Drug Corp for Hemabate 250 mcg/ml ampules, with an ultimate completion date of September 17, 2025. This non-set-aside contract represents a small-value pharmaceutical procurement delivered to the place of performance in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp fulfills this order under its...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Hemabate 250 micrograms per milliliter in ampule form. This firm fixed-price delivery order, valued at $2,119.75, is non-set-aside and scheduled for completion by September 29, 2025. The award is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,666.41, is for the supply of HEMABATE 250 MCG/ML AMPULML, a pharmaceutical product. The contract is a firm fixed-price delivery order with an ultimate completion date of April 18, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distributor AmerisourceBergen Corporation. The $8,777.92 firm fixed price delivery order is for the supply of HEMABATE 250 MCG/ML AMPULML, a prescription medication. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, valued at up to $999,999,999.00 and running through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for HEMABATE 250 MCG/ML ampules, with a ceiling value of $4,239.50 under a firm fixed-price contract structure. This non-set-aside award was issued on September 26, 2025, with an ultimate completion date of September 29, 2025. HEMABATE (carboprost tromethamine) is a pharmaceutical product used in obstetric and gynecological applications. The performance location is AmerisourceBergen Drug Corp's corporate...
- This is a $3,329.01 firm fixed-price delivery order contract awarded by the Medical Supply Chain division of the U.S. Department of Defense's Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation. The contract is for the supply of HEMABATE 250 MCG/ML AMPULML, a pharmaceutical product, with a period of performance through May 10, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to...
- This federal contract award, valued at $7,696.30, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of HEMABATE 250 MCG/ML AMPULML, a pharmaceutical product, with a completion date of February 23, 2024. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which serves as a critical supplier of pharmaceutical products and medical supplies to...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $6,072.86 to AmerisourceBergen Drug Corp on June 25, 2025, with completion targeted for July 23, 2025. The award covers HCG MDV 10,000U 10ML in single-unit quantities under a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical procurement vendor. The contract represents a...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a $27,999.27 delivery order by the Defense Logistics Agency's Medical Supply Chain on July 24, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The company serves as a critical pharmaceutical distributor for federal medical...